6-29987248-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000688495.1(POLR1HASP):​n.361-9853A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0527 in 152,208 control chromosomes in the GnomAD database, including 259 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.053 ( 259 hom., cov: 33)

Consequence

POLR1HASP
ENST00000688495.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.805

Publications

14 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000688495.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000688495.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLR1HASP
ENST00000688495.1
n.361-9853A>G
intron
N/A
POLR1HASP
ENST00000849678.1
n.588+34419A>G
intron
N/A
POLR1HASP
ENST00000849680.1
n.506-30498A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0527
AC:
8009
AN:
152090
Hom.:
259
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0492
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0633
Gnomad ASJ
AF:
0.175
Gnomad EAS
AF:
0.0388
Gnomad SAS
AF:
0.0592
Gnomad FIN
AF:
0.0238
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0516
Gnomad OTH
AF:
0.0587
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0527
AC:
8023
AN:
152208
Hom.:
259
Cov.:
33
AF XY:
0.0531
AC XY:
3955
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0493
AC:
2046
AN:
41504
American (AMR)
AF:
0.0632
AC:
966
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
606
AN:
3466
East Asian (EAS)
AF:
0.0389
AC:
202
AN:
5188
South Asian (SAS)
AF:
0.0605
AC:
292
AN:
4830
European-Finnish (FIN)
AF:
0.0238
AC:
252
AN:
10610
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0516
AC:
3506
AN:
68002
Other (OTH)
AF:
0.0577
AC:
122
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
340
679
1019
1358
1698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0536
Hom.:
342
Bravo
AF:
0.0538
Asia WGS
AF:
0.0450
AC:
156
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
7.6
DANN
Benign
0.65
PhyloP100
0.81

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3901554;
hg19: chr6-29955025;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.